Indonesian State Firm Faces IDR 1.6 Trillion Debt in 2025

State-owned PT Bio Farma (Persero) is projected to have outstanding debts of IDR 1.6 trillion (approximately USD 100 million) to third parties by 2025, according to publicly available information. These debts reportedly include payments to event organizers (EOs) and consulting services. This information suggests potential financial challenges for the company, which could impact its future operations. As state-owned enterprises often provide services directly linked to public welfare, their financial health is crucial for public trust. PT Bio Farma is a key player in Indonesia's pharmaceutical and biotechnology sector, involved in vaccine production and drug development. Its financial status is also relevant to the domestic healthcare and public health sectors. The background to these outstanding debts may involve the execution of large-scale projects and the associated increase in outsourced expenses. State-owned enterprises are expected to operate efficiently and sustainably while pursuing the public interest, making their response to this debt issue a point of attention. Source: Sindonews